Healthcare-associated infection (HAI) surveillance data can be used to estimate the scope, spread and location of infections, monitor trends, evaluate preventive efforts, and improve practices, policy and facility planning. In Sweden, national point prevalence surveys (PPS) have been conducted twice yearly in all county councils since 2008.
Aim:
The aim of this study was to identify key obstacles concerning the HAI surveillance process.
Methods:
Twenty-two infection control practitioners (ICPs) from all county councils in Sweden were interviewed, using semi-structured interview guides. Data were analysed using qualitative content analysis.
Results:
Sixteen types of obstacles pertaining to four surveillance stages were identified. Most obstacles were associated with the first two stages, which meant that the latter stages of this process, i.e. the use of the results to reduce HAI, were underdeveloped. The ICPs observed scepticism towards both the PPS methodology itself and the quality of the HAI data collected in the PPS, which hinders HAI surveillance realising its full potential in Swedish healthcare.
ChristoffelTGallagherSS. (1999) Injury Prevention and Public Health. Gaithersburg, MD: Aspen Publishers.
3.
DamschroderLJBanaszak-HollJKowalskiCPFormanJSaintSKreinSL. (2009) The role of the “champion” in infection prevention: results from a multisite qualitative study. Quality and Safety in Health Care18: 434–440.
4.
EmmersonAM. (1995) The impact of surveys on hospital infection. Journal of Hospital Infection30(Suppl): 421–440.
5.
EmmersonAMEnstoneJEGriffinMKelseyMCSmythET. (1996) The second national prevalence survey of infection in hospitals – overview of the results. Journal of Hospital Infection32: 175–190.
6.
EmoriTGCulverDHHoranTCJarvisWRWhiteJWOlsonDRBanerjeeSEdwardsJRMartoneWJGaynesRPHughesJM. (1991) National nosocomial infections surveillance system (NNIS): Description of surveillance methods. American Journal of Infection Control19: 19–35.
7.
EriksenHMIversenBAavitslandP. (2005) Prevalence of nonsocomial infections in hospitals in Norway, 2002 and 2003. Journal of Hospital Infection60: 40–45.
8.
FreemanJHutchinsonGB. (1980) Prevalence, incidence and duration. American Journal of Epidemiology112: 707–723.
9.
GastmeierPKampfGHauerTSchlingmannJSchumacherMDaschnerFRüdenH. (1998) Experience with two validation methods in a prevalence survey on nonsocomial infections. Infection Control and Hospital Epidemiology19: 668–673.
10.
GastmeierPSohrDSchwabFBehnkeMZuschneidIBrandtCDettenkoferMChabernyIFRüdenHGeffersC. (2008) Ten years of KISS: the most important requirements for success. Journal of Hospital Infection70(Suppl 1): 11–16.
11.
HajduAEriksenHMSorknesNKHaugeSHLoewerHLIversenBGAavitslandP. (2011) Evaluation of the national surveillance system for point-prevalence of healthcare-associated infections in hospitals and in long-term care facilities for elderly in Norway, 2002–2008. BMC Public Health11: 923.
12.
HaleyRW. (1995) The scientific basis for using surveillance and risk factor data to reduce nonsocomial infection rates. Journal of Hospital Infection30(Suppl): 3–14.
13.
HsiehHFShannonSE. (2005) Three approaches to qualitative content analysis. Qualitative Health Research15: 1277–1288.
14.
HumphreysHSmythETM. (2006) Prevalence surveys of healthcare-associated infections: what do they tell us, if anything?Clinical Microbiology and Infection12: 2–4.
15.
HumphreysHNewcombeRGEnstoneJEmmersonAMHumphreysHFitzpatrickFDaviesENewcombeRGSpencerRC; on behalf of the Hospital Infection Society Steering Group. (2008) Four country healthcare associated infection prevalence survey 2006: risk factor analysis. Journal of Hospital Infection69: 249–257.
16.
IrvineADrewPSainsburyR. (2013) ‘Am I not answering your questions properly?’ Clarification, adequacy and responsiveness in semi-structured telephone and face-to-face interviews. Qualitative Research13: 87–106.
17.
LizioliAPriviteraGAlliataEAntonietta BanfiEMBoselliLPanceriMLPernaMCPorrettaADSantiniMGCarreriV. (2003) Prevalence of nonsocomial infections in Italy: result from the Lombardy survey in 2000. Journal of Hospital Infection54: 141–148.
18.
LlataEGaynesRPFridkinS. (2009) Measuring the scope and magnitude of hospital-associated infection in the United States: the value of prevalence surveys. Clinical Infectious Diseases48: 1434–1440.
19.
LyytikäinenOKanervaMAgtheNMöttönenTRuutuP; the Finnish Prevalence Survey Study Group. (2008) Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. Journal of Hospital Infection69: 288–294.
20.
MarshallMN. (1996) The key informant technique. Family Practice13: 92–97.
21.
Ministry of Education and Research. (2003) SFS (2003:460) [Ethical Approval Act of Research Involving Humans]. Stockholm: Ministry of Education and Research.
22.
Ministry of Health and Social Affairs. (2011) Hälso- och sjukvårdslag 1982:763 [Health Care Act 1982:763]. Stockholm: Ministry of Health and Social Affairs.
23.
O’BoyleCJacksonMHenleySJ. (2002) Staffing requirements for infection control programs in US health care facilities: Delphi project. American Journal of Infection Control30: 321–333.
24.
RogersEM. (2003) Diffusion of Innovations. 5th edition.New York: Free Press.
SALAR (SKL). (2015) Nationell satsning för ökad patientsäkerhet. Mätning av vårdrelaterade infektioner inom sluten somatisk och psykiatrisk vård v. 12-13, 2015 [National initiative for increased patient safety. Measurement of health care-associated infection in somatic in-patient and psychiatric care, week 12-13, 2015. Available at: http://skl.se/halsasjukvard/patientsakerhet/vardrelateradeinfektioner/matningavvriochbhk.4721.html (accessed 20 January 2015).
27.
StonePWDickAPogorzelskaMHoranTCFuruyaEYLarsonE. (2009) Staffing and structure of infection prevention and control programs. American Journal of Infection Control37: 351–357.
28.
Van der KooiTIIManniënJWilleJCvan BenthemBH (2010) Prevalence of nosocomial infections in The Netherlands, 2007–2008: results of the first four national studies. Journal of Hospital Infection75: 168–172.
